Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Abstract

Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of myocardial infarction.

References

Page 1

	Year	Citations
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia M. H. Frick, Olli Elo, Kauko Haapa, New England Journal of Medicine	1987	3.9K
A Multiple Testing Procedure for Clinical Trials Peter C. O’Brien, Thomas R. Fleming Biometrics Multiple Testing ProcedurePsychiatryClinical Trial ManagementHealth PolicyTreatment Plan Evaluation	1979	3.3K
MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Stanley Peart, Greta Barnes, George Broughton, BMJ HypertensionPlacebo TabletsPharmacotherapyBlood PressureThrombosis	1985	1.5K
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. M. F. Oliver, J. A. Heady, J Morris, Heart	1978	1.1K
Modelling Survival Data in Medical Research. Geoffrey J. McLachlan, D. Collett Biometrics Prognostic AssessmentSurvival DataPrognosisMedicineClinical Data	1994	1K
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Curt D. Furberg, Hadie Adams, William B. Applegate, Circulation	1994	875
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels J. Wouter Jukema, Albert V.G. Bruschke, Ad J. van Boven, Circulation	1995	842
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease JAMA	1984	780
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS) MAAS Investigators The Lancet ThrombosisVascular DiseaseCoronary AtheromaCardiovascular DiseaseMedicine	1994	650
The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering JAMA Lipid DisorderPreventive MedicineCardiovascular EpidemiologyCardiovascular DiseaseHealth Policy	1984	644

Page 1